Company: INMB
Filing Date: 2025-06-16
Form Type: S-8
Source: 0001213900-25-054427
Chunk: 10

Company: Inmune Bio, Inc.
Filing Date: 2025-06-16
Form: S-8
Chunk 10
---
 Plan, of which options to purchase 28,194 shares are vested; and (e) options to purchase  
 32,500 shares of common stock exercisable at an exercise price of $5.05 per share pursuant to the 2021 Plan, of which none are vested.  |

| (6) | Includes: (a) vested options to purchase 19,025 shares of common stock                                                                  
 exercisable at an exercise price of $17.49 per share pursuant to the 2021 Plan; (b) vested options to purchase 35,000 shares of common  
 stock at an exercise price of $7.92 per share pursuant to the 2021 Plan; (c) vested options to purchase 12,500 shares of common stock   
 at an exercise price of $9.92 per share pursuant to the 2021 Plan; (d) options to purchase 19,024 shares of common stock at an exercise 
 price of $9.74 per share pursuant to the 2021 Plan, of which options to purchase 15,325 shares are vested; and (e) options to purchase  
 32,500 shares of common stock exercisable at an exercise price of $5.05 per share pursuant to the 2021 Plan, of which none are vested.  |

| (7) | Includes the following 7 named non-affiliate persons, each                                                                                
 of whom holds at least 1,000 Shares of Class A common stock or equity awards issuable for an amount equal to 1% or more of the securities 
 issuable pursuant to the Company’s 2021 Stock Option Plan: Christopher Barnum, Josh Schoonover, Kim Staats, Cory Ellspermann, Tara        
 Lehner, Parris Pope and Therese Blomberg.                                                                                                 |

<div align='center'>4

PLAN OF DISTRIBUTION</div>

Timing of Sales

The selling stockholders may offer and sell the shares covered by this reoffer prospectus at various times. The selling stockholders will act independently of our company in making decisions with respect to the timing, manner and size of each sale.

To our knowledge, no selling stockholder has any
agreement or understanding, directly or indirectly, with any person to resell the shares of common stock covered by this reoffer prospectus.

Offering Price

The sales price offered by the selling stockholders
to the public may be:

| 1. | the market price prevailing at the time of sale; |

|